62 results
8-K
EX-1.1
bwzvzfyu1
14 Feb 24
Other Events
4:11pm
424B5
3yz0fi ui4zax83xhv4
14 Feb 24
Prospectus supplement for primary offering
4:09pm
424B5
8vq9fjzrw2kk0gd bow4
13 Feb 24
Prospectus supplement for primary offering
4:36pm
S-3ASR
EX-4.4
xivz39o
13 Feb 24
Automatic shelf registration
4:04pm
8-K
EX-2.1
g1rc121 yw7jjjc2ycd
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:05am